Arming Immune Cells for Battle: A Brief Journey through the Advancements of T and NK Cell Immunotherapy

Arming Immune Cells for Battle: A Brief Journey through the Advancements of T and NK Cell Immunotherapy

The promising development of adoptive immunotherapy over the last four decades has revealed numerous therapeutic approaches in which dedicated immune cells are modified and administered to eliminate malignant cells. Starting in the early 1980s, lymphokine activated killer (LAK) cells were the first...

Full description

Bibliographic Details
Main Authors: Philipp Wendel, Lisa Marie Reindl, Tobias Bexte, Leander Künnemeyer, Vinzenz Särchen, Nawid Albinger, Andreas Mackensen, Eva Rettinger, Tobias Bopp, Evelyn Ullrich
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Cancers
Subjects:
NK cell
T cell
CIK cell
NK-92
cell therapy
immune therapy
Online Access:https://www.mdpi.com/2072-6694/13/6/1481

Internet

https://www.mdpi.com/2072-6694/13/6/1481

Similar Items